Bioequivalence and Statistics in Clinical Pharmacology

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $110.75
Usually ships in 1-2 business days
(Save 7%)
Other sellers (Hardcover)
  • All (3) from $110.75   
  • New (1) from $111.94   
  • Used (2) from $110.75   

Overview

Maintaining a practical perspective, Bioequivalence and Statistics in Clinical Pharmacology explores statistics used in day-to-day clinical pharmacology work. The book covers the methods needed to design, analyze, and interpret bioequivalence trials; explores when, how, and why these studies are performed as part of drug development; and demonstrates the proposed methods using real world examples.

Drawing on knowledge gained directly from working in the pharmaceutical industry, the authors set the stage by describing the general role of statistics. Once the foundation of clinical pharmacology drug development, regulatory applications, and the design and analysis of bioequivalence trials are established, they move on to related topics in clinical pharmacology involving the use of cross-over designs. These include, but are not limited to, safety studies in Phase I, dose-response trials, drug interaction trials, food-effect and combination trials, QTc and other pharmacodynamic equivalence trials, and dose-proportionality trials. Purposefully designed to be instantly applicable, the book provides examples of SAS code so that the analysis described can be immediately implemented. The authors have made extensive use of the proc mixed procedures available in SAS.

Each chapter includes a vignette based on co-author Scott Patterson's experience in the clinical pharmacology work place and all the data sets are taken from real trials. The authors delineate practical utility and objectives, provide real-world examples of the topic under discussion, and include statistical theory and applications. Technical theory, where extensive, is included in technical appendices at the end of the chapter. Each topic contains worked examples that illustrate the applications of the statistical techniques and their interpretation. The authors also develop statistical tools useful for other topics of clinical pharmacology - namely general safety testing, testing for proarrythmic potential, population pharmacokinetics, and dose-selection.

Read More Show Less

Product Details

  • ISBN-13: 9781584885306
  • Publisher: Taylor & Francis
  • Publication date: 11/28/2005
  • Series: Chapman & Hall/CRC Biostatistics Series
  • Edition description: New Edition
  • Pages: 400
  • Product dimensions: 6.20 (w) x 9.30 (h) x 1.00 (d)

Table of Contents

DRUG DEVELOPMENT AND CLINICAL PHARMACOLOGY
Aims of This Book
Drug Development
Clinical Pharmacology
Statistics in Clinical Pharmacology
Structure of the Book

HISTORY AND REGULATION OF BIOEQUIVALENCE
When and How BE Studies Are Performed
Why Are BE Studies Performed?
Deciding When Formulations Are Bioequivalent
Potential Issues with TOST Bioequivalence
Current International Regulation

TESTING FOR AVERAGE BIOEQUIVALENCE
Background
Linear Model for 2 x 2 Data
Applying the TOST Procedure
Carry-over, Sequence, and Interaction Effects
Checking Assumptions Made about the Linear Model
Power and Sample Size for ABE in the 2 x 2 Design
Example Where Test and Reference Are Not ABE
Nonparametric Analysis
Some Practical Issues

BE STUDIES WITH MORE THAN TWO PERIODS
Background
Three-period Designs
Within-subject Variability
Robust Analyses for Three Period Designs
Four-Period Designs
Designs with More than Two Treatments
Nonparametric Analyses of Tmax
Technical Appendix: Efficiency
Tables of Data

DEALING WITH UNEXPECTED BE CHALLENGES
Restricted Maximum Likelihood Modelling
Failing BE and the DER Assessment
Simulation
Data-Based Simulation
Carry-Over
Optional Designs
Determining Trial Size
What Outliers are and How to Handle Their Data
Bayesian BE Assessment
Technical Appendix

THE FUTURE AND RECENT PAST OF BE TESTING
Brief History
Individual and Population BE
Scaled Average BE

CLINICAL PHARMACOLOGY SAFETY STUDIES
Background
First-time-in-humans
Sub-chronic Dosing Studies
Food-Effect Assessment and DDIs
Dose-Proportionality
Technical Appendix

QTC
Background
Modelling of QTc Data
Interpreting the QTc Modelling Findings
Design of a Thorough QTc Study in the Future
Technical Appendix

CLINICAL PHARMACOLOGY EFFICACY STUDIES
Background
Sub-chronic Dosing
Phase IIa and the Proof of Concept
Methodology Studies

POPULATION PHARMACOKINETICS
Population and Pharmacokinetics
Absolute and Relative Bioavailability
Age and Gender Pharmacokinetic Studies
Ethnicity
Liver Disease
Kidney Disease
Technical Appendix

Epilogue
Bibliography
Index

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)